HEPION PHARMACEUTICALS, INC. Taxes Payable, Current
HEPION PHARMACEUTICALS, INC. (HEPA) had Taxes Payable, Current of $0 as of 2021-12-31, per its 10-K filed 2022-04-08.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:TaxesPayableCurrent · last filed 2022-04-08
- 2021-12-31: Taxes Payable, Current $0.00.
- 2021-09-30: Taxes Payable, Current $0.00.
- 2021-06-30: Taxes Payable, Current $29.18K.
- 2021-03-31: Taxes Payable, Current $0.00.
| Period end | Taxes Payable, Current | Taxes Payable, Current as first filed |
|---|---|---|
| 2021-12-31 | $0.00 10-K · filed 2022-04-08 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $29.18K 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-14 | |
| 2020-12-31 | $37.16K 10-K · filed 2022-04-08 | |
| 2020-09-30 | $522.08K 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $89.39K 10-Q · filed 2020-08-12 | |
| 2020-03-31 | $74.36K 10-Q · filed 2020-06-29 | |
| 2019-12-31 | $431.92K 10-K · filed 2021-03-31 | $74.36K 10-Q · filed 2020-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |